nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP3A4—Temozolomide—malignant glioma	0.468	1	CbGbCtD
Ciclesonide—Hyperadrenocorticism—Temozolomide—malignant glioma	0.072	0.157	CcSEcCtD
Ciclesonide—Impaired healing—Carmustine—malignant glioma	0.0266	0.058	CcSEcCtD
Ciclesonide—Oral candidiasis—Carmustine—malignant glioma	0.0181	0.0395	CcSEcCtD
Ciclesonide—Oral candidiasis—Temozolomide—malignant glioma	0.0175	0.0381	CcSEcCtD
Ciclesonide—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.0135	0.0294	CcSEcCtD
Ciclesonide—Candida infection—Carmustine—malignant glioma	0.011	0.0239	CcSEcCtD
Ciclesonide—Candida infection—Temozolomide—malignant glioma	0.0106	0.0231	CcSEcCtD
Ciclesonide—Diabetes mellitus—Carmustine—malignant glioma	0.00961	0.0209	CcSEcCtD
Ciclesonide—Swelling—Carmustine—malignant glioma	0.00948	0.0206	CcSEcCtD
Ciclesonide—Ear pain—Temozolomide—malignant glioma	0.00947	0.0206	CcSEcCtD
Ciclesonide—Gastroenteritis—Temozolomide—malignant glioma	0.00912	0.0198	CcSEcCtD
Ciclesonide—Nasal congestion—Temozolomide—malignant glioma	0.00887	0.0193	CcSEcCtD
Ciclesonide—Face oedema—Carmustine—malignant glioma	0.00807	0.0176	CcSEcCtD
Ciclesonide—Face oedema—Temozolomide—malignant glioma	0.0078	0.017	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00713	0.0155	CcSEcCtD
Ciclesonide—Bronchitis—Temozolomide—malignant glioma	0.00672	0.0146	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00649	0.0141	CcSEcCtD
Ciclesonide—Pneumonia—Carmustine—malignant glioma	0.00648	0.0141	CcSEcCtD
Ciclesonide—Weight increased—Temozolomide—malignant glioma	0.00635	0.0138	CcSEcCtD
Ciclesonide—CES1—Irinotecan Pathway—BCHE—malignant glioma	0.00635	0.0871	CbGpPWpGaD
Ciclesonide—Urinary tract infection—Carmustine—malignant glioma	0.00626	0.0136	CcSEcCtD
Ciclesonide—Pneumonia—Temozolomide—malignant glioma	0.00626	0.0136	CcSEcCtD
Ciclesonide—Infestation NOS—Temozolomide—malignant glioma	0.00623	0.0136	CcSEcCtD
Ciclesonide—Infestation—Temozolomide—malignant glioma	0.00623	0.0136	CcSEcCtD
Ciclesonide—Urinary tract infection—Temozolomide—malignant glioma	0.00605	0.0132	CcSEcCtD
Ciclesonide—Sinusitis—Temozolomide—malignant glioma	0.00584	0.0127	CcSEcCtD
Ciclesonide—Haemoglobin—Carmustine—malignant glioma	0.00581	0.0127	CcSEcCtD
Ciclesonide—Haemorrhage—Carmustine—malignant glioma	0.00578	0.0126	CcSEcCtD
Ciclesonide—Haemoglobin—Temozolomide—malignant glioma	0.00562	0.0122	CcSEcCtD
Ciclesonide—Haemorrhage—Temozolomide—malignant glioma	0.00559	0.0122	CcSEcCtD
Ciclesonide—Pharyngitis—Temozolomide—malignant glioma	0.00555	0.0121	CcSEcCtD
Ciclesonide—Immune system disorder—Temozolomide—malignant glioma	0.00505	0.011	CcSEcCtD
Ciclesonide—Mediastinal disorder—Temozolomide—malignant glioma	0.00504	0.011	CcSEcCtD
Ciclesonide—Back pain—Carmustine—malignant glioma	0.00487	0.0106	CcSEcCtD
Ciclesonide—Dysgeusia—Temozolomide—malignant glioma	0.00476	0.0104	CcSEcCtD
Ciclesonide—Back pain—Temozolomide—malignant glioma	0.00471	0.0102	CcSEcCtD
Ciclesonide—Angioedema—Temozolomide—malignant glioma	0.00445	0.00968	CcSEcCtD
Ciclesonide—Hypertension—Carmustine—malignant glioma	0.00435	0.00946	CcSEcCtD
Ciclesonide—Palpitations—Temozolomide—malignant glioma	0.0043	0.00936	CcSEcCtD
Ciclesonide—Chest pain—Carmustine—malignant glioma	0.00429	0.00933	CcSEcCtD
Ciclesonide—Cough—Temozolomide—malignant glioma	0.00425	0.00924	CcSEcCtD
Ciclesonide—Hypertension—Temozolomide—malignant glioma	0.0042	0.00914	CcSEcCtD
Ciclesonide—Arthralgia—Temozolomide—malignant glioma	0.00414	0.00902	CcSEcCtD
Ciclesonide—Infection—Carmustine—malignant glioma	0.00408	0.00889	CcSEcCtD
Ciclesonide—Dry mouth—Temozolomide—malignant glioma	0.00405	0.00882	CcSEcCtD
Ciclesonide—Infection—Temozolomide—malignant glioma	0.00394	0.00859	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00374	0.00815	CcSEcCtD
Ciclesonide—Dyspnoea—Carmustine—malignant glioma	0.00366	0.00797	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00362	0.00787	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Carmustine—malignant glioma	0.00355	0.00772	CcSEcCtD
Ciclesonide—Dyspnoea—Temozolomide—malignant glioma	0.00354	0.00771	CcSEcCtD
Ciclesonide—Dyspepsia—Temozolomide—malignant glioma	0.0035	0.00761	CcSEcCtD
Ciclesonide—CES1—Irinotecan Pathway—APC—malignant glioma	0.00345	0.0473	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00343	0.00746	CcSEcCtD
Ciclesonide—Fatigue—Temozolomide—malignant glioma	0.00342	0.00745	CcSEcCtD
Ciclesonide—Urticaria—Temozolomide—malignant glioma	0.00315	0.00687	CcSEcCtD
Ciclesonide—Asthenia—Carmustine—malignant glioma	0.00295	0.00642	CcSEcCtD
Ciclesonide—Asthenia—Temozolomide—malignant glioma	0.00285	0.0062	CcSEcCtD
Ciclesonide—Dizziness—Carmustine—malignant glioma	0.00272	0.00591	CcSEcCtD
Ciclesonide—Dizziness—Temozolomide—malignant glioma	0.00263	0.00572	CcSEcCtD
Ciclesonide—Rash—Carmustine—malignant glioma	0.00259	0.00564	CcSEcCtD
Ciclesonide—Dermatitis—Carmustine—malignant glioma	0.00259	0.00563	CcSEcCtD
Ciclesonide—Headache—Carmustine—malignant glioma	0.00257	0.0056	CcSEcCtD
Ciclesonide—CYP2D6—CYP2E1 reactions—CYP2B6—malignant glioma	0.00254	0.0349	CbGpPWpGaD
Ciclesonide—Rash—Temozolomide—malignant glioma	0.0025	0.00545	CcSEcCtD
Ciclesonide—Dermatitis—Temozolomide—malignant glioma	0.0025	0.00544	CcSEcCtD
Ciclesonide—Headache—Temozolomide—malignant glioma	0.00249	0.00541	CcSEcCtD
Ciclesonide—Nausea—Carmustine—malignant glioma	0.00244	0.00531	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—FTH1—malignant glioma	0.0024	0.033	CbGpPWpGaD
Ciclesonide—Nausea—Temozolomide—malignant glioma	0.00236	0.00513	CcSEcCtD
Ciclesonide—CYP2D6—Fatty acids—CYP2B6—malignant glioma	0.00198	0.0272	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.00186	0.0255	CbGpPWpGaD
Ciclesonide—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00179	0.0246	CbGpPWpGaD
Ciclesonide—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.00158	0.0216	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—malignant glioma	0.00144	0.0197	CbGpPWpGaD
Ciclesonide—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.00137	0.0187	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00121	0.0166	CbGpPWpGaD
Ciclesonide—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—malignant glioma	0.00117	0.016	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—malignant glioma	0.00109	0.0149	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00103	0.0141	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—malignant glioma	0.00101	0.0139	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—SLC5A5—malignant glioma	0.000961	0.0132	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYB—malignant glioma	0.000954	0.0131	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—SOX2—malignant glioma	0.000943	0.0129	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—malignant glioma	0.000923	0.0127	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.00092	0.0126	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—SLC6A3—malignant glioma	0.000915	0.0125	CbGpPWpGaD
Ciclesonide—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000893	0.0123	CbGpPWpGaD
Ciclesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—malignant glioma	0.00085	0.0117	CbGpPWpGaD
Ciclesonide—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000837	0.0115	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—malignant glioma	0.000784	0.0108	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—GSTP1—malignant glioma	0.000774	0.0106	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—CDKN2A—malignant glioma	0.000747	0.0102	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000743	0.0102	CbGpPWpGaD
Ciclesonide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000707	0.0097	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000674	0.00924	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000654	0.00898	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000646	0.00886	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—NCOR1—malignant glioma	0.000619	0.00849	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—PDGFB—malignant glioma	0.000612	0.00839	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptors—PPARG—malignant glioma	0.000596	0.00818	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—GJA1—malignant glioma	0.000589	0.00807	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.000574	0.00788	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000567	0.00778	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00056	0.00768	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.000544	0.00747	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000531	0.00728	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—HIF1A—malignant glioma	0.000522	0.00716	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—MYC—malignant glioma	0.000506	0.00694	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000502	0.00689	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—malignant glioma	0.00049	0.00673	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.000485	0.00665	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.000479	0.00657	CbGpPWpGaD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.000471	0.00646	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00046	0.00631	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000459	0.00629	CbGpPWpGaD
Ciclesonide—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000455	0.00624	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.000454	0.00623	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—HLA-A—malignant glioma	0.00045	0.00617	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—HIF1A—malignant glioma	0.00043	0.0059	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000428	0.00587	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000422	0.00579	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—NOTCH1—malignant glioma	0.000397	0.00544	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—APC—malignant glioma	0.000388	0.00532	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000377	0.00518	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000377	0.00518	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.000373	0.00511	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000371	0.00509	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000366	0.00502	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000349	0.00478	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000347	0.00476	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—NCOR1—malignant glioma	0.000311	0.00427	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00031	0.00425	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.000308	0.00422	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000301	0.00413	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IFNG—malignant glioma	0.0003	0.00412	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000282	0.00387	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CXCL8—malignant glioma	0.000279	0.00383	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000278	0.00381	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00027	0.00371	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL2—malignant glioma	0.000267	0.00366	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malignant glioma	0.000264	0.00363	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—malignant glioma	0.000263	0.00361	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—HIF1A—malignant glioma	0.000262	0.0036	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—malignant glioma	0.000252	0.00346	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PTEN—malignant glioma	0.000251	0.00344	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.00025	0.00343	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	0.000246	0.00337	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000244	0.00335	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000241	0.00331	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	0.000235	0.00322	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000228	0.00313	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000227	0.00311	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARG—malignant glioma	0.000223	0.00306	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000216	0.00296	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.00021	0.00288	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	0.000209	0.00286	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000198	0.00271	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.000186	0.00255	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000185	0.00254	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000184	0.00253	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000182	0.00249	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	0.000171	0.00235	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.00016	0.00219	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000158	0.00216	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000155	0.00213	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	0.000151	0.00207	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000147	0.00202	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000141	0.00193	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000141	0.00193	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000139	0.00191	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000138	0.0019	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000138	0.0019	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000137	0.00188	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—malignant glioma	0.000137	0.00188	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000135	0.00185	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000129	0.00177	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000129	0.00177	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	0.000127	0.00175	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000121	0.00166	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00012	0.00164	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000119	0.00164	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—malignant glioma	0.000118	0.00162	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000114	0.00156	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT3B—malignant glioma	0.000106	0.00146	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HIST1H3B—malignant glioma	0.000103	0.00141	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000102	0.0014	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—RTEL1—malignant glioma	9.06e-05	0.00124	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	8.96e-05	0.00123	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	8.83e-05	0.00121	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	8.62e-05	0.00118	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	8.14e-05	0.00112	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—H3F3A—malignant glioma	7.97e-05	0.00109	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—COX8A—malignant glioma	7.95e-05	0.00109	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH3—malignant glioma	7.48e-05	0.00103	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ASMT—malignant glioma	6.76e-05	0.000928	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH2—malignant glioma	6.71e-05	0.00092	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BCAN—malignant glioma	6.36e-05	0.000872	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CDKN2B—malignant glioma	5.77e-05	0.000791	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NCOR1—malignant glioma	5.47e-05	0.00075	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—COX8A—malignant glioma	5.2e-05	0.000713	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—IDH2—malignant glioma	5.13e-05	0.000703	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.82e-05	0.000661	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	4.64e-05	0.000637	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ASMT—malignant glioma	4.42e-05	0.000607	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—IDH1—malignant glioma	4.41e-05	0.000605	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SPHK1—malignant glioma	4.27e-05	0.000585	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2C18—malignant glioma	4.18e-05	0.000573	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BCAN—malignant glioma	4.16e-05	0.00057	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH1—malignant glioma	4.15e-05	0.00057	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARG—malignant glioma	3.92e-05	0.000538	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTT1—malignant glioma	3.38e-05	0.000464	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—IDH2—malignant glioma	3.35e-05	0.00046	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS1—malignant glioma	3.17e-05	0.000434	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.15e-05	0.000432	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BCHE—malignant glioma	2.94e-05	0.000404	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.91e-05	0.000399	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—IDH1—malignant glioma	2.88e-05	0.000395	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SPHK1—malignant glioma	2.79e-05	0.000383	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.73e-05	0.000375	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTP1—malignant glioma	2.34e-05	0.000321	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAT—malignant glioma	2.28e-05	0.000313	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—malignant glioma	2.23e-05	0.000306	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTT1—malignant glioma	2.21e-05	0.000303	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOR1—malignant glioma	2.15e-05	0.000295	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS1—malignant glioma	2.07e-05	0.000284	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BCHE—malignant glioma	1.92e-05	0.000264	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.9e-05	0.000261	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAV1—malignant glioma	1.75e-05	0.000241	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.6e-05	0.000219	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—malignant glioma	1.55e-05	0.000213	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARG—malignant glioma	1.54e-05	0.000212	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTP1—malignant glioma	1.53e-05	0.00021	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAT—malignant glioma	1.49e-05	0.000204	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000193	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.41e-05	0.000193	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.22e-05	0.000168	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—malignant glioma	1.21e-05	0.000166	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAV1—malignant glioma	1.15e-05	0.000157	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—malignant glioma	1.06e-05	0.000145	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.05e-05	0.000143	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARG—malignant glioma	1.01e-05	0.000138	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.19e-06	0.000126	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.01e-06	0.00011	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—malignant glioma	7.93e-06	0.000109	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—malignant glioma	7.47e-06	0.000102	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—malignant glioma	6.92e-06	9.49e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—malignant glioma	6.1e-06	8.37e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.88e-06	6.7e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—malignant glioma	3.99e-06	5.47e-05	CbGpPWpGaD
